Clinical Cancer Advances 2015: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Cet article présente le rapport annuel de l'"American Society of Clinical Oncology" sur les principales avancées cliniques en 2015
Clinical cancer research has yielded tremendous gains, leading to longer survival and better quality of life for the more than half a million Americans diagnosed with the disease each year. Great strides in cancer prevention have further decreased the burden of the disease. Cancer death rates in the United States have declined 20% from their peak in 1991 (215.1 per 100,000 population) to 2010 (171.8 per 100,000 population).1 Today, there are a record 14.5 million cancer survivors alive in the United States. Now in its 10th year, the American Society of Clinical Oncology's (ASCO's) report, “Clinical Cancer Advances 2015: An Annual Report on Progress Against Cancer,” for the first time identifies ASCO's Advance of the Year. Other new features in this special anniversary issue include: A Decade in Review, which recounts the biggest changes in cancer care since this report's introduction; The 10-Year Horizon, which previews trends likely to shape the next decade of cancer care; and a special series of research, which highlights exciting new leads for treatment of rare cancers. In keeping with this report's tradition, we explore the clinical advances of the prior year that stand to make the biggest impact on improving cancer prevention, treatment, and care. The following is a summary of some of the most exciting trends and developments.